Literature DB >> 2839718

Retrovirus-expressed hemagglutinin protects against lethal influenza virus infections.

L A Hunt1, D W Brown, H L Robinson, C W Naeve, R G Webster.   

Abstract

An influenza virus hemagglutinin gene, H7, has been expressed in a replication-competent Schmidt-Ruppin Rous sarcoma virus-derived vector. This virus, P1/H7, expressed a glycosylated precursor of the H7 protein which was processed to a mature form and transported to the cell surface. The expressed H7 glycoprotein could not be detected in P1/H7 virus particles. A P1/H7 stock which expressed 5 to 10% of the level of H7 observed in influenza virus-infected chicken embryo fibroblasts was used to immunize 1-month-old chickens. This immunization resulted in low or undetectable levels of hemagglutination-inhibiting and neutralizing antibody. Despite the low serum response, challenge with a highly pathogenic H7N7 virus revealed complete protection against lethal infection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2839718      PMCID: PMC253740          DOI: 10.1128/JVI.62.8.3014-3019.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

Review 1.  Vaccinia virus expression vectors.

Authors:  B Moss; C Flexner
Journal:  Annu Rev Immunol       Date:  1987       Impact factor: 28.527

2.  Characterization of temperature sensitive influenza virus mutants defective in neuraminidase.

Authors:  P Palese; K Tobita; M Ueda; R W Compans
Journal:  Virology       Date:  1974-10       Impact factor: 3.616

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  The structure and function of the hemagglutinin membrane glycoprotein of influenza virus.

Authors:  D C Wiley; J J Skehel
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

Review 5.  Influenza virus A pathogenicity: the pivotal role of hemagglutinin.

Authors:  R G Webster; R Rott
Journal:  Cell       Date:  1987-08-28       Impact factor: 41.582

6.  Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution.

Authors:  I A Wilson; J J Skehel; D C Wiley
Journal:  Nature       Date:  1981-01-29       Impact factor: 49.962

7.  Characterization of an influenza A virus from seals.

Authors:  R G Webster; V S Hinshaw; W J Bean; K L Van Wyke; J R Geraci; D J St Aubin; G Petursson
Journal:  Virology       Date:  1981-09       Impact factor: 3.616

8.  Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors.

Authors:  S H Hughes; J J Greenhouse; C J Petropoulos; P Sutrave
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

9.  Molecular analysis of the hemagglutinin genes of Australian H7N7 influenza viruses: role of passerine birds in maintenance or transmission?

Authors:  A Nestorowicz; Y Kawaoka; W J Bean; R G Webster
Journal:  Virology       Date:  1987-10       Impact factor: 3.616

10.  Analysis of progressive deletions of the transmembrane and cytoplasmic domains of influenza hemagglutinin.

Authors:  C Doyle; J Sambrook; M J Gething
Journal:  J Cell Biol       Date:  1986-10       Impact factor: 10.539

View more
  10 in total

Review 1.  Success factors for avian influenza vaccine use in poultry and potential impact at the wild bird-agricultural interface.

Authors:  David E Swayne; Erica Spackman; Mary Pantin-Jackwood
Journal:  Ecohealth       Date:  2013-09-12       Impact factor: 3.184

2.  Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines.

Authors:  Shixia Wang; Jessica Taaffe; Christopher Parker; Alicia Solórzano; Hong Cao; Adolfo García-Sastre; Shan Lu
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

Review 3.  Non-replicating expression vectors: applications in vaccine development and gene therapy.

Authors:  K J Limbach; E Paoletti
Journal:  Epidemiol Infect       Date:  1996-06       Impact factor: 2.451

4.  Complementation between avirulent Newcastle disease virus and a fusion protein gene expressed from a retrovirus vector: requirements for membrane fusion.

Authors:  T Morrison; C McQuain; L McGinnes
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

5.  DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations.

Authors:  E F Fynan; R G Webster; D H Fuller; J R Haynes; J C Santoro; H L Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

6.  Transfer of a mutant dihydrofolate reductase gene into pre- and postimplantation mouse embryos by a replication-competent retrovirus vector.

Authors:  H Stuhlmann; R Jaenisch; R C Mulligan
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

7.  One Group's Historical Reflections on DNA Vaccine Development.

Authors:  Ellen F Fynan; Shan Lu; Harriet L Robinson
Journal:  Hum Gene Ther       Date:  2018-08-21       Impact factor: 5.695

Review 8.  Viral vectors for veterinary vaccines.

Authors:  M Sheppard
Journal:  Adv Vet Med       Date:  1999

Review 9.  Prevalence and control of H7 avian influenza viruses in birds and humans.

Authors:  E M Abdelwhab; J Veits; T C Mettenleiter
Journal:  Epidemiol Infect       Date:  2014-01-15       Impact factor: 4.434

10.  AIV polyantigen epitope expressed by recombinant baculovirus induces a systemic immune response in chicken and mouse models.

Authors:  Lei Yu; Jun Pan; Guangli Cao; Mengsheng Jiang; Yunshan Zhang; Min Zhu; Zi Liang; Xing Zhang; Xiaolong Hu; Renyu Xue; Chengliang Gong
Journal:  Virol J       Date:  2020-08-05       Impact factor: 4.099

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.